Welltower Inc. (WELL), the world's largest healthcare real estate investment trust (REIT) and an S&P 500 constituent focused on senior housing, outpatient medical buildings, and post-acute care properties, saw its shares drop sharply in Tuesday's session. The stock declined 5.22% to about $228.06, down from Monday's closing price of $240.61. The sell-off was driven by a mixed third-quarter earnings report: revenue beat expectations and full-year guidance was raised, but net income attributable to common stockholders missed analyst forecasts, triggering a round of profit-taking after a strong recent rally.
The earnings-driven move followed Welltower's third-quarter results, released after Monday's close. The company posted net income attributable to common stockholders of $0.54 per share, falling $0.11 short of the $0.65 consensus estimate. Meanwhile, revenue reached $3.72 billion, topping the $3.66 billion estimate and rising 15.8% year over year. Normalized funds from operations (FFO) of $1.67 per share climbed 24.6% from the prior-year period.
Management also raised its full-year outlook, lifting net income guidance to a range of $3.31 to $3.37 per share (from $3.11 to $3.19 previously) and increasing normalized FFO guidance to $6.47 to $6.53 per share (from $6.36 to $6.44). Despite the improved forecast, investors focused on the bottom-line miss, and the stock reversed lower.
Beneath the headline miss, Welltower's core senior housing business continued to perform well. The Seniors Housing Operating (SHO) portfolio delivered 21.0% year-over-year same-store net operating income growth, supported by 320 basis points of average occupancy gains and 5.3% growth in revenue per occupied room. The company completed $4.1 billion of pro rata gross investments during the quarter, including $2.7 billion across 43 seniors housing properties, and declared a quarterly dividend of $0.85 per share payable November 19.
The magnitude of Tuesday's decline also reflected positioning rather than purely fundamental disappointment. WELL had climbed from roughly $221 in early October to a recent high of $240.61 on Monday, leaving the stock technically overbought and vulnerable to a pullback. Once the earnings miss surfaced, short-term traders and momentum investors locked in gains, accelerating the downside move.
Trading volume was elevated relative to typical levels as investors reacted to the earnings release, consistent with an event-driven repricing. The decline appeared largely company-specific, as broader healthcare REIT peers did not show the same magnitude of weakness, underscoring that the move was tied to Welltower's results and valuation rather than a sector-wide shift. The stock also fell below its recent $237–$240 trading range, a technical development that added to selling pressure in the session.
Looking ahead, investors will monitor whether Welltower can sustain its senior housing operating momentum and whether the raised full-year guidance translates into actual bottom-line delivery. Key areas of focus include occupancy trends, integration of recently acquired communities, and any further capital recycling activity. Risks include execution challenges on a large acquisition pipeline, potential cost inflation, and valuation sensitivity given the stock's premium to historical multiples. The company's dividend declaration and continued liquidity of approximately $9.5 billion provide some financial stability as the market digests the mixed report.
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with each bot varying by strategy, timeframe, performance metrics, and traded symbols. The curated Trending AI Robots section highlights only the strongest performers at any given time, helping traders identify strategies that are adapting well to evolving market dynamics. Explore the page to discover which automated approaches are currently leading the field.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
WELL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 22 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 62 cases where WELL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.
The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In 34 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
WELL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for WELL entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
WELL moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for WELL crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 54%.
Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in 229 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.804) is normal, around the industry mean (3.134). WELL has a moderately high P/E Ratio (110.365) as compared to the industry average of (30.791). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). Dividend Yield (0.014) settles around the average of (0.050) among similar stocks. WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines